Tvardi Therapeutics is trading 6.06% higher at $1.40 after hours, with no confirmed company-specific catalyst identified.
- The stock closed at $1.32 on September 23, 2026.
- Available coverage identified no new company announcement, earnings release, or filing; the latest investor-relations materials showed no September 23 update.
- Broader equities declined amid higher yields and inflation concerns, but that does not clearly explain the after-hours rebound.